NCT05803096View on ClinicalTrials.gov

Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

143

Participants

Timeline

Start Date

December 12, 2021

Primary Completion Date

September 2, 2022

Study Completion Date

September 9, 2022

Conditions
Prostate DiseaseMalignancyBenign Prostatic HyperplasiaProstate CancerProstate AdenocarcinomaAnxiety and FearPain
Interventions
DRUG

Self-Administered Nitrous Oxide

Nitrous oxide administered at concentrations of mild sedation (20-45%) for the duration of prostate biopsy.

OTHER

Oxygen

Oxygen will be administered at 10 Liters/min for the duration of prostate biopsy.

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

lead

Beth Israel Deaconess Medical Center

OTHER

NCT05803096 - Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain | Biotech Hunter | Biotech Hunter